Rationale and design of the Turkish acute myocardial infarction registry : The TURKMI Study
OBJECTIVE: To the best of our knowledge, there is no up-to-date information regarding the presentation, management, and clinical course of patients with acute myocardial infarction (MI) in Turkey. The TURKMI registry is designed to provide an insight into the characteristics, management from the symptoms onset to the hospital discharge, and outcome of patients with acute MI in Turkey.
METHODS: The TURKMI study, as a nationwide registry, will be conducted in 50 percutaneous coronary intervention-capable centers, selected from each EuroStat NUTS region in Turkey according to their population sampling weight, prioritizing the hospital volume in each region. All consecutive patients with acute MI admitted to the coronary care units within the 48 hours of the symptoms onset will be prospectively enrolled during a predefined 2-week period. The first step of the study has a cross-sectional design in which baseline information such as symptoms, risk factors, time periods at each step from the symptoms onset to revascularization, way of arrival to hospital, biochemical analysis, and in-hospital management and outcome will be assessed. The second step has a cohort characteristic in which the enrolled patients will be followed-up up to 2 years. Follow-up visits will be conducted at the 1st, 6th, 12th, and 24th month, and predictors and risk of cardiovascular events and implementation of guidelines will be assessed as secondary outcomes.
CONCLUSION: The national TURKMI registry is expected to provide important information to improve the national policy regarding diagnosing, management, and outcomes of MI in Turkey.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Anatolian journal of cardiology - 23(2020), 3 vom: 01. Feb., Seite 169-175 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Erol, Mustafa Kemal [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical Trial Protocol |
---|
Anmerkungen: |
Date Completed 23.11.2020 Date Revised 23.11.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.14744/AnatolJCardiol.2019.57522 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307121674 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307121674 | ||
003 | DE-627 | ||
005 | 20231225124850.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.14744/AnatolJCardiol.2019.57522 |2 doi | |
028 | 5 | 2 | |a pubmed24n1023.xml |
035 | |a (DE-627)NLM307121674 | ||
035 | |a (NLM)32120363 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Erol, Mustafa Kemal |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rationale and design of the Turkish acute myocardial infarction registry |b The TURKMI Study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.11.2020 | ||
500 | |a Date Revised 23.11.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To the best of our knowledge, there is no up-to-date information regarding the presentation, management, and clinical course of patients with acute myocardial infarction (MI) in Turkey. The TURKMI registry is designed to provide an insight into the characteristics, management from the symptoms onset to the hospital discharge, and outcome of patients with acute MI in Turkey | ||
520 | |a METHODS: The TURKMI study, as a nationwide registry, will be conducted in 50 percutaneous coronary intervention-capable centers, selected from each EuroStat NUTS region in Turkey according to their population sampling weight, prioritizing the hospital volume in each region. All consecutive patients with acute MI admitted to the coronary care units within the 48 hours of the symptoms onset will be prospectively enrolled during a predefined 2-week period. The first step of the study has a cross-sectional design in which baseline information such as symptoms, risk factors, time periods at each step from the symptoms onset to revascularization, way of arrival to hospital, biochemical analysis, and in-hospital management and outcome will be assessed. The second step has a cohort characteristic in which the enrolled patients will be followed-up up to 2 years. Follow-up visits will be conducted at the 1st, 6th, 12th, and 24th month, and predictors and risk of cardiovascular events and implementation of guidelines will be assessed as secondary outcomes | ||
520 | |a CONCLUSION: The national TURKMI registry is expected to provide important information to improve the national policy regarding diagnosing, management, and outcomes of MI in Turkey | ||
650 | 4 | |a Clinical Trial Protocol | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
700 | 1 | |a Kayıkçıoğlu, Meral |e verfasserin |4 aut | |
700 | 1 | |a Kılıçkap, Mustafa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Anatolian journal of cardiology |d 2014 |g 23(2020), 3 vom: 01. Feb., Seite 169-175 |w (DE-627)NLM239682068 |x 2149-2271 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2020 |g number:3 |g day:01 |g month:02 |g pages:169-175 |
856 | 4 | 0 | |u http://dx.doi.org/10.14744/AnatolJCardiol.2019.57522 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2020 |e 3 |b 01 |c 02 |h 169-175 |